Broadwood Partners, L.P. has bought stock on 38 days since Mar 2018

Broadwood Partners, L.P. is a Delaware limited partnership and pooled investment vehicle managed by Broadwood Capital, Inc., a New York City–based private investment firm formed in 2002 and registered with the U.S. Securities and Exchange Commission.( Broadwood Partners, L.P. is one of Broadwood Capital’s primary advisory clients and serves sophisticated investors through an actively managed portfolio reviewed on a daily basis, with reporting provided under the terms of its limited partnership agreement.( The partnership is organized in Delaware and maintains its principal business contact through Broadwood Capital, Inc. at offices in New York.(

Broadwood Partners, L.P. is best known as a significant, long-term shareholder and activist investor in healthcare and medical technology companies, including its role as a more-than 10% owner of STAAR Surgical Company (NASDAQ: STAA).( As of recent SEC ownership reports, Broadwood Partners, L.P. and affiliates have held a substantial stake in STAAR Surgical and have publicly engaged with the company’s strategic direction, including commenting on shareholder actions related to a proposed sale of STAAR to Alcon Inc.( Beyond STAAR, the partnership has also reported large, often activist positions in issuers such as Lineage Cell Therapeutics and Insight Molecular Diagnostics, reflecting a concentrated, research-driven investment approach under the leadership of Broadwood Capital’s president and principal owner, Neal C. Bradsher.(

Written by Perplexity from public sources.